| Entry |
|
|---|
| Name |
Glipizide and metformin hydrochloride;
Metaglip (TN) |
|---|
| Product |
|
|---|
| Generic |
GLIPIZIDE AND METFORMIN HCL (Chartwell RX), GLIPIZIDE AND METFORMIN HCL (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals), GLIPIZIDE AND METFORMIN HCL (Proficient Rx LP), GLIPIZIDE AND METFORMIN HCL (REMEDYREPACK), GLIPIZIDE AND METFORMIN HYDROCHLORIDE (A-S Medication Solutions), GLIPIZIDE AND METFORMIN HYDROCHLORIDE (AvKARE), GLIPIZIDE AND METFORMIN HYDROCHLORIDE (REMEDYREPACK), GLIPIZIDE AND METFORMIN HYDROCHLORIDE (REMEDYREPACK), GLIPIZIDE AND METFORMIN HYDROCHLORIDE (Teva Pharmaceuticals USA), GLIPIZIDE AND METFORMIN HYDROCHLORIDE (Zydus Lifesciences Limited), GLIPIZIDE AND METFORMIN HYDROCHLORIDE (Zydus Pharmaceuticals USA) |
|---|
| Component |
|
|---|
| Class |
Antidiabetic agent
DG02044 Hypoglycemic agent
DG03033 Combination of metformin and sulfonylurea
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidiabetic |
|---|
| Disease |
Type 2 diabetes mellitus [DS: H00409] |
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BD Combinations of oral blood glucose lowering drugs
A10BD02 Metformin and sulfonylureas
D10265 Glipizide and metformin hydrochloride <US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Combinations
Glipizide/ Metformin Hydrochloride
D10265 Glipizide and metformin hydrochloride
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG03033 Combination of metformin and sulfonylurea
D10265 Glipizide and metformin hydrochloride
Drug classes [BR:br08332]
Antidiabetic agent
DG02044 Hypoglycemic agent
D10265 Glipizide and metformin hydrochloride
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
